Search the Newsreel

Enovix Corp (ENVX) COO Michael Vyvoda named insider in new Form 3

Enovix Corp (ENVX) has filed an initial Form 3, reporting that Michael Vyvoda, the Chief Operating Officer, is now a reporting person. The filing itself does not indicate any transactions or derivative positions but does note the attachment of a Power of Attorney as …

Sapient Capital LLC Acquires 56,444 Shares of ServiceNow, Inc. $NOW

Sapient Capital LLC significantly increased its stake in ServiceNow, Inc. by 266% in the second quarter, acquiring an additional 56,444 shares, bringing its total holdings to 77,661 shares valued at approximately $7.71 million. This increase follows ServiceNow's strong quarterly earnings, where it reported $0.90 …

Hong Kong Stock Market Movement | Lenovo Group (00992) Rises Nearly 3%, Hitting a Record High; Q1 Earnings to Be Released This Thursday

Bionano Genomics (BNGO) Earnings Date and Reports 2026

GCM Grosvenor (GCMG) Earnings Date and Reports 2026

Cenovus Energy Inc (CVE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Brokers Issue Forecasts for XENE Q1 Earnings

Tenon Medical Implements 1-for-35 Reverse Stock Split; Today

(RTTNews) - Tenon Medical, Inc. (TNON) announced on Thursday, August 6, 2026, that it will implement a 1-for-35 reverse stock split today effective at 12:01, Eastern Time, on August 10, 2026. The company confirmed that its shares will begin trading on a split-adjusted basis …

Quantinno Capital Management LP Purchases 30,816 Shares of Xenon Pharmaceuticals Inc. $XENE

Quantinno Capital Management LP significantly increased its stake in Xenon Pharmaceuticals Inc. by 125.1% in the first quarter, acquiring an additional 30,816 shares. The biopharmaceutical company, which has no product sales, reported a narrower-than-expected quarterly loss of $1.11 per share. Analyst sentiment remains largely …

ServiceNow Stock Jumped 9% This Week as AI Contract Value Tops $1 Billion

ServiceNow (NOW) shares surged this week after its Q2 earnings report demonstrated strong growth, particularly in AI monetization, with annual contract value exceeding $1 billion for the first time. The company's subscription revenue grew 23% in constant currency, defying the "SaaSpocalypse" narrative. Key drivers …

ServiceNow (NOW) Unveils Autonomous Security to Accelerate Growth

ServiceNow has announced six new Autonomous Security solutions under "Shift Zero" to enhance its cybersecurity offerings. The company's security and risk business has already surpassed $1 billion in annual contract value and is growing rapidly, boasting a 98% renewal rate. Despite its growth, the …

(CVE) Volatility Zones as Tactical Triggers

This article analyzes Cenovus Energy Inc (NYSE: CVE) using AI models to identify volatility zones and tactical triggers for trading. It highlights a weak near-term sentiment challenging long-term strength, an exceptional short setup, and divergent sentiment across different time horizons. The analysis provides specific …

Enovis (ENOV) Reaffirmed Guidance And Improved Margins, Is The Stock Still Undervalued?

Enovis (ENOV) reaffirmed its full-year 2026 revenue guidance and reported improved Q2 results, including organic growth and margin improvement, leading to a smaller net loss. Despite recent stock performance showing some momentum, the company is still considered undervalued by analysts, trading below the fair …

Enterprise value to EBIT forward of 10x Genomics Inc Class A – BMV:TXG

This article provides financial information for 10x Genomics Inc Class A (BMV:TXG) on TradingView. It specifically highlights the company's enterprise value to EBIT forward metric. The content appears to be a stub or a placeholder page within a larger financial data platform.

Terreno Realty Corp (T37) Q1 2025 Earnings Report - Results, Call & Slides

Terreno Realty Corp (T37) has released its Q1 2025 earnings report, showing an actual EPS of €0.42, beating the consensus of €0.32, and an actual revenue of €95.56M, surpassing the expected €93.51M. The company's revenue also saw a significant year-over-year growth of 29.86%. The …

Enovix Stock (ENVX) Opinions on Upcoming Earnings

Should You Investigate Enovis Corporation (NYSE:ENOV) At US$26.61?

This article evaluates Enovis Corporation's (NYSE:ENOV) stock at its current price of US$26.61. It will likely delve into financial metrics, analyst sentiment, and market conditions to determine if it's an attractive investment opportunity.

NewEdge Advisors LLC Lowers Stake in ServiceNow, Inc. $NOW

NewEdge Advisors LLC reduced its stake in ServiceNow, Inc. by 16.2% in the first quarter, selling 26,213 shares and retaining 135,683 shares valued at approximately $14.2 million. Despite this reduction, institutional investors and hedge funds collectively own a significant 87.18% of the company. Analysts …

Avity Investment Management Inc. Trims Stock Holdings in ServiceNow, Inc. $NOW

Avity Investment Management Inc. has reduced its stake in ServiceNow, Inc. (NYSE:NOW) by 9.1% in the second quarter, selling 15,987 shares and retaining 159,103 shares valued at approximately $15.8 million. Despite this trimming by one firm, institutional investors collectively own 87.18% of the company's …

What Terreno Realty (TRNO)'s Dividend Hike And Data Center Leases Mean For Shareholders

Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Análisis y previsión de acciones de ServiceNow Inc (NOW)

3 Financially Fit Penny Stocks Retail Investors Are Finding Right Now

This article identifies three "financially fit" penny stocks: Enovix (ENVX), Grab Holdings (GRAB), and Clover Health Investments (CLOV). It highlights their respective market opportunities—advanced battery technology, Southeast Asian super app, and tech-driven Medicare Advantage plans—while also noting associated risks and financial metrics. The article …

Enovis Q2 Earnings Call Highlights

Enovis reported Q2 2026 sales of $583 million, a 3% increase, driven by growth in its Reconstruction business despite challenges from the Middle East conflict and inflation. The company reaffirmed its full-year guidance, expecting sales growth to accelerate in Q4 with new product launches. …

Bionano Genomics | 8-K: Current report

This article is a current report (8-K filing) from Bionano Genomics. It provides links to two separate documents for more details. The content explicitly states that it is for informational and educational purposes only and does not constitute investment advice.

Terreno Realty (TRNO) Stock Faces Repeatability Questions As FFO Rises

Enovis (NYSE:ENOV) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Enovis (ENOV) reported Q2 earnings of $0.9 per share, exceeding the Zacks Consensus Estimate of $0.83, and revenues of $582.78 million, also surpassing estimates. The company has consistently beaten EPS estimates over the last four quarters and revenue estimates three out of the last …

FDA Pre-NDA Progress On Azetukalner Could Be A Game Changer For Xenon Pharmaceuticals (XENE)

Xenon Pharmaceuticals reported a net loss of US$110.74 million in Q2 2026, but its successful pre-NDA meeting with the FDA for azetukalner and a US$1.20 billion cash balance position it for potential regulatory milestones. The company is on track to submit an NDA for …

Kenon Holdings Ltd (KEN) Stock News Today

This article provides current stock information for Kenon Holdings Ltd (KEN), including its market cap, P/E ratio, and recent stock performance. It notes that more news regarding the company's earnings and analyst ratings will be available soon. The content emphasizes that TradingKey offers general …

GCMG|GCM Grosvenor Inc|Price:13.580|Chg%:+0.100

Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $32

Evercore has reiterated its Buy rating on Enovis Corp (ENOV.US) and maintained its target price at $32. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Scotiabank Sticks to Its Buy Rating for Terreno Realty (TRNO)

Xenon Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $81.21, Implies 26% Upside

Xenon Pharmaceuticals Inc. (XENE) has seen its average 12-month price target increased by analysts to $81.21, up from $80.8, with a potential upside of approximately 26% based on its recent closing price. The consensus rating remains a "Buy" from 18 covering analysts, indicating strong …

Gradient Investments LLC Increases Holdings in ServiceNow, Inc. $NOW

Gradient Investments LLC has increased its stake in ServiceNow, Inc. by 39.9% during the second quarter, now holding 259,557 shares valued at approximately $25.8 million. Other institutional investors also significantly increased their positions. ServiceNow reported strong quarterly earnings, beating estimates with EPS of $0.90 …

MFG Wealth Management Inc. Takes Position in NeoGenomics, Inc. $NEO

MFG Wealth Management Inc. has initiated a position in NeoGenomics, Inc. (NASDAQ:NEO) by purchasing 83,462 shares valued at approximately $1.22 million, representing about 0.06% of the company. Institutional investors and hedge funds collectively own 98.5% of NeoGenomics, which has received a "Moderate Buy" consensus …

First Trust Advisors LP Sells 351,606 Shares of Enovix Corporation $ENVX

First Trust Advisors LP has reduced its stake in Enovix Corporation (NASDAQ:ENVX) by 42.4% in the first quarter, selling 351,606 shares and retaining 476,903 shares valued at approximately $2.47 million. The company reported a quarterly loss of $0.14 per share, beating estimates, with revenue …